Cargando…

TERT promoter mutations and gene amplification: Promoting TERT expression in Merkel cell carcinoma

Telomerase activation through the induction of its catalytic component TERT is essential in carcinogenesis. The regulatory mechanism and clinical significance underlying cancer-specific TERT expression have been extensively investigated in various human malignancies, but little is known about these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Hong, Liu, Tiantian, Wang, Na, Björnhagen, Viveca, Höög, Anders, Larsson, Catharina, Lui, Weng-Onn, Xu, Dawei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259404/ https://www.ncbi.nlm.nih.gov/pubmed/25301727

Ejemplares similares

MicroRNA Expression Patterns Related to Merkel Cell Polyomavirus Infection in Human Merkel Cell Carcinoma
por: Xie, Hong, et al.
Publicado: (2014)

MiR-375 Regulation of LDHB Plays Distinct Roles in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma
por: Kumar, Satendra, et al.
Publicado: (2018)

Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes
por: Kumar, Satendra, et al.
Publicado: (2019)

Sex Differences in Overall Survival and the Effect of Radiotherapy in Merkel Cell Carcinoma—A Retrospective Analysis of A Swedish Cohort
por: Björn Andtback, Hannah, et al.
Publicado: (2021)

The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors
por: Liu, Tiantian, et al.
Publicado: (2014)

The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma
por: Yuan, Xiaotian, et al.
Publicado: (2017)

TERT promoter mutations and monoallelic activation of TERT in cancer
por: Huang, F W, et al.
Publicado: (2015)

TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas
por: Wang, Kun, et al.
Publicado: (2014)

Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?
por: Hellgren, L Samuel, et al.
Publicado: (2022)

TERT Promoter Mutations Increase Sense and Antisense Transcription from the TERT Promoter
por: Hafezi, François, et al.
Publicado: (2021)

TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance
por: Liu, Tiantian, et al.
Publicado: (2023)

TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer
por: da Silva, Edaise M., et al.
Publicado: (2021)

Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications
por: Liu, Tiantian, et al.
Publicado: (2016)

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2021)

5hmC Immunohistochemistry: A Predictor of TERT Promoter Mutational Status in Follicular Thyroid Carcinoma?
por: Hysek, Martin, et al.
Publicado: (2023)

TERT promoter mutations in melanoma survival
por: Nagore, Eduardo, et al.
Publicado: (2019)

The Solo Play of TERT Promoter Mutations
por: Hafezi, François, et al.
Publicado: (2020)

TERT Promoter Mutations and Telomerase in Melanoma
por: Guo, Yuchen, et al.
Publicado: (2022)

TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma
por: Paulsson, Johan O., et al.
Publicado: (2018)

Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease
por: Hysek, Martin, et al.
Publicado: (2019)

TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation
por: Vallarelli, Andrelou F., et al.
Publicado: (2016)

Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers
por: Stern, Josh Lewis, et al.
Publicado: (2015)

Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression
por: Salgado, Catarina, et al.
Publicado: (2020)

TERT promoter hotspot mutations in breast cancer
por: Shimoi, Tatsunori, et al.
Publicado: (2017)

TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma
por: Zhang, Yifan, et al.
Publicado: (2021)

Frequent somatic TERT promoter mutations and CTNNB1 mutations in hepatocellular carcinoma
por: Lee, Seung Eun, et al.
Publicado: (2016)

Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma
por: Lee, Hye Won, et al.
Publicado: (2017)

Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2017)

Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations
por: Park, Hyunju, et al.
Publicado: (2021)

TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas
por: Gupta, Sounak, et al.
Publicado: (2021)

Germline TERT promoter mutations are rare in familial melanoma
por: Harland, Mark, et al.
Publicado: (2015)

Human TERT Promoter Mutations in Atypical and Anaplastic Meningiomas
por: Mellai, Marta, et al.
Publicado: (2021)

Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid Carcinoma
por: Jeon, Min Ji, et al.
Publicado: (2016)

Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations
por: Hahn, Soo Yeon, et al.
Publicado: (2017)

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma
por: Rusinek, Dagmara, et al.
Publicado: (2020)

TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma
por: Griewank, Klaus G., et al.
Publicado: (2013)

Merkel cell polyomavirus T-antigens regulate DICER1 mRNA stability and translation through HSC70
por: Gao, Jiwei, et al.
Publicado: (2021)

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
por: Remke, Marc, et al.
Publicado: (2013)

Cancer-associated TERT promoter mutations abrogate telomerase silencing
por: Chiba, Kunitoshi, et al.
Publicado: (2015)

TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma
por: Mosrati, Mohamed Ali, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e7l8k4bboebg21ciiroo8f3r5c